The estimated Net Worth of Michael Lane is at least $11.9 Milion dollars as of 14 February 2024. Mr. Lane owns over 939 units of Idexx Laboratories stock worth over $3,297,489 and over the last 6 years he sold IDXX stock worth over $7,113,410. In addition, he makes $1,473,880 as Executive Vice President, General Manager a Reference Laboratories and Information Technology at Idexx Laboratories.
Sign up
Mr. Lane IDXX stock SEC Form 4 insiders trading
Michael has made over 15 trades of the Idexx Laboratories stock since 2018, according to the Form 4 filled with the SEC. Most recently he exercised 939 units of IDXX stock worth $460,354 on 14 February 2024.
The largest trade he's ever made was selling 17,961 units of Idexx Laboratories stock on 5 August 2019 worth over $4,743,500. On average, Michael trades about 3,965 units every 125 days since 2018. As of 14 February 2024 he still owns at least 6,726 units of Idexx Laboratories stock.
You can see the complete history of Mr. Lane stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Michael Lane biography
Michael J. Lane serves as Executive Vice President, General Manager, Reference Laboratories and Information Technology of the Company. Mr. Lane has been a Corporate Vice President since July 2015 and General Manager of IDEXX’s Global Reference Laboratories business since November 2016. Prior to becoming the General Manager of our Global Reference Laboratories business, he served as the General Manager of the Company’s U.S. Reference Laboratories from June 2014, and as Vice President from 2012, until July 2015. In addition to his responsibilities for the Reference Laboratories business, from July 2015 through December 2016, Mr. Lane provided strategic direction for the Company’s SNAP® Point-of-Care testing. Mr. Lane joined IDEXX in 1997, supporting strategic planning and business development for diagnostic laboratory services as IDEXX entered the global reference laboratory market segment. In 1999, he joined the IDEXX VetLab organization, where he held various leadership positions with responsibilities in commercial marketing, product management, and new product development, and served from 2012 to May 2014 as Vice President and General Manager. Mr. Lane holds a bachelor’s degree in international politics and economics from Middlebury College and an M.B.A. from the Tuck School of Business at Dartmouth College.
What is the salary of Michael Lane?
As the Executive Vice President, General Manager a Reference Laboratories and Information Technology of Idexx Laboratories, the total compensation of Michael Lane at Idexx Laboratories is $1,473,880. There are 6 executives at Idexx Laboratories getting paid more, with Jonathan Ayers having the highest compensation of $8,309,800.
How old is Michael Lane?
Michael Lane is 52, he's been the Executive Vice President, General Manager a Reference Laboratories and Information Technology of Idexx Laboratories since 2020. There are 22 older and 2 younger executives at Idexx Laboratories. The oldest executive at Idexx Laboratories, Inc. is M. Anne Szostak, 69, who is the Independent Director.
What's Michael Lane's mailing address?
Michael's mailing address filed with the SEC is ONE IDEXX DRIVE, , WESTBROOK, ME, 04092.
Insiders trading at Idexx Laboratories
Over the last 22 years, insiders at Idexx Laboratories have traded over $238,711,289 worth of Idexx Laboratories stock and bought 24,695 units worth $3,109,424 . The most active insiders traders include Stuart Essig, Johnny D Powers a Jonathan W Ayers. On average, Idexx Laboratories executives and independent directors trade stock every 9 days with the average trade being worth of $4,641,291. The most recent stock trade was executed by M Anne Szostak on 5 September 2024, trading 500 units of IDXX stock currently worth $234,685.
What does Idexx Laboratories do?
idexx laboratories, inc. (nasdaq: idxx) is a leader in pet healthcare innovation, serving practicing veterinarians around the world with a broad range of diagnostic and information technology-based products and services. headquartered in southern maine, idexx conducts operations through more than 70 locations around the world, serves customers in over 175 countries, and employs more than 6,000 people. idexx's primary business focuses on pet health, a growing market around the world. idexx products —in-clinic diagnostic tests and instrumentation, reference laboratory and telemedicine consultation services, and practice management software—enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and to build more economically successful practices. idexx also develops and manufactures diagnostic tests and information for the global production animal industry, including poultry and livestock, as well as tests for the quality and safety of water an
What does Idexx Laboratories's logo look like?
Complete history of Mr. Lane stock trades at Idexx Laboratories
Idexx Laboratories executives and stock owners
Idexx Laboratories executives and other stock owners filed with the SEC include:
-
Jonathan Ayers,
Director -
Jonathan Mazelsky,
President, Chief Executive Officer, Director -
Brian McKeon,
Chief Financial Officer, Executive Vice President, Treasurer -
Kathy Turner,
Corporate Vice President and Chief Marketing Officer -
Jonathan J. Mazelsky,
Pres, CEO & Director -
Sharon Underberg,
Corporate Vice President, General Counsel, and Corporate Secretary -
Michael Lane,
Executive Vice President, General Manager, Reference Laboratories and Information Technology -
Brian P. McKeon,
CFO, Exec. VP & Treasurer -
Giovani Twigge,
Chief Human Resource Officer, Corporate Vice President -
Dr. Nimrata Khatra Hunt P.E., Ph.D.,
Exec. VP and GM - Point of Care Diagnostics & Worldwide Operations -
Michael J. Lane,
Exec. VP and GM of Reference Laboratories & Information Technology -
James F. Polewaczyk,
Exec. VP & Chief Commercial Officer -
Sharon E. Underberg,
Exec. VP, Gen. Counsel, & Corp. Sec. -
Lawrence Kingsley,
Independent Chairman of the Board -
M. Anne Szostak,
Independent Director -
Daniel Junius,
Independent Director -
Bruce Claflin,
Independent Director -
Rebecca Henderson,
Independent Director -
Sophie Vandebroek,
Independent Director -
Stuart Essig,
Independent Director -
Sam Samad,
Independent Director -
Jonathan W. Ayers,
Sr. Advisor & Director -
Asha Collins,
Independent Director -
James Polewaczyk,
Executive Vice President and Chief Commercial Officer -
Tina Hunt,
Executive Vice President, General Manager, Point of Care Diagnostics and Worldwide Operations -
Dr. Martin Smith Ph.D.,
Exec. VP & CTO -
Ken Grady,
Sr. VP & Chief Information Officer -
Martin Smith,
Exec. VP & CTO -
Jeffery D. Chadbourne,
Sr. Director of Accounting & Financial Reporting -
John Hart,
Sr. VP of Worldwide Operations -
Barry C Johnson,
Director -
Thomas Craig,
Director -
William End,
Director -
Jacqueline Studer,
CVP, Gen. Counsel & Secretary -
Thomas J Dupree,
Corporate Vice President -
Michael J Williams,
Corporate Vice President -
Daniel V Meyaard,
Corporate Vice President -
Conan R Deady,
Vice President and Secretary -
Joseph V Vumbacco,
Director -
William E Iii Brown,
Corporate Vice President -
William B. Goodspeed,
Corporate Vice President -
Robert J Murray,
Director -
Jeffrey Fiarman,
EVP, GEN COUNSEL & SECRETARY -
Ali Naqui,
Vice President -
Johnny D Powers,
Corporate Vice President -
Errol B Desouza,
Director -
William C Wallen,
SVP & Chief Scientific Officer -
Quentin J Tonelli,
Vice President -
S Sam Fratoni,
Vice President -
Irene C Kerr,
Corporate Vice President -
Robert S Hulsy,
Vice President -
Laurel E Labauve,
Vice President -
Merilee Raines,
Vice President,CFO & Treasurer -
James L Jr Moody,
Director -
Jennifer A Joiner,
Corp VP CAG N American CommOps -
Louis W Pollock,
Senior Vice President -
Erwin R Jr Workman,
Executive Vice President -
Nimrata Hunt,
Executive Vice President -
Irene Chang Britt,
Director -
Martin Alexander Smith,
Executive Vice President -
Michael Perkins Johnson,
EVP and CHRO -
George Fennell,
SVP, Chief Revenue Officer -
Michael G Erickson,
Executive Vice President -
Michael Schreck,
Executive Vice President